Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Product/Service, Trade Show

Ayala Pharmaceuticals Announces Presentation at the European Society for Medical Oncology (ESMO)


Ayala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers, today announced that a poster will be presented at the European Society for Medical Oncology (ESMO), being held in Barcelona, Spain from September 27 to October 1, 2019.

Presentation information is as follows:

Title: ACCURACY a phase (P) 2 trial of AL101, a pan-Notch inhibitor, in recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) patients (pts) with Notch activating mutations (Notchact mut): preliminary safety and efficacy data 
Session Title: Poster Display Session 
Session Date and Time: Monday, September 30, 2019 at 12:00pm to 1:00pm CET 
Presentation Number: 1148P 
Location: Poster Area (Hall 4) 
Presenter: Alan L. Ho, M.D., Ph.D., Memorial Sloan Kettering Cancer Center

About Ayala Pharmaceuticals

Ayala Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers. Ayala is broadly developing its product candidates, AL101 and AL102, best-in-class gamma secretase inhibitors, with clinical and preclinical studies underway in both solid tumors (AL101) and hematologic malignancies (AL102). Ayala's lead product candidate, AL101, is currently in phase 2 for adenoid cystic carcinoma patients with tumor bearing Notch activating mutations (ACCURACY). For more information, visit www.ayalapharma.com


These press releases may also interest you

at 14:05
YC-Backed Yoneda Labs Raises $4 Million Seed Led by Khosla Ventures to Build Foundation Model for Chemists
Yoneda Labs, the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator....

at 14:02
doxo Responds to U.S. Federal Trade Commission's Misguided Litigation
Yesterday, the U.S Federal Trade Commission filed a lawsuit against doxo, a company working to deliver a better bill-paying experience for consumers and billers, with a complaint that indicates a fundamental misunderstanding of the existing bill-pay...

at 14:00
Bailey & Galyen Obtains $3 Million Verdict in Railway Attack Case Against Allied Universal Security Services
Attorneys Scott Robelen and Clint Lee, of Bailey & Galyen Attorneys at Law, achieved a $3 million award for their client, John Farley, in a case against Allied Universal Security Services. Farley, a 39-year-old conductor, was brutally attacked at the...

at 13:50
Phenom Releases Massive Wave of HR Tech Innovation: Talent Experience Engine, Next-GenAI Agents, New Platform Experiences, and Updates for Talent Acquisition and Talent Management
During its IAMPHENOM 2024 Product Innovation Keynote, Phenom announced a massive wave of platform innovations ? including Talent Experience Engine, X+ Agents, Talent Marketer Experience and Talent Leader Experience. These innovations deliver unique...

at 13:50
Northeast Regional Sales Manager Bill LeBeau Elevated to Senior Sales Manager of Distribution and Corporate Accounts at Bishop-Wisecarver
Bishop-Wisecarver, the leading provider of linear and rotary motion products, is proud to announce the promotion of Bill LeBeau to the position of Senior Manager of Distribution and Corporate Accounts. With over 13 years of dedicated service to...

at 13:15
Biz Apps Partner Summit for Microsoft Ecosystem to Deliver FY 25 Insights
Dynamics Communities and Community Summit North America, in collaboration with Microsoft, are introducing the Biz Apps Partner Summit to run July 24-25, 2024, in Bellevue, Washington delivering a 24-hour immersion into FY 25 priorities, opportunities...

More news about Science and technology...


News published on and distributed by: